Table 3

CAP pathogens and treatments administered
OutpatientsaN=340 Inpatients N=241 Total N=581 p
Microbiological study
Non-studied, n 221 0 221
Studied, n 119 241 360
Negative, n 47 127 174
Pathogen identified, n 72 114 186
Streptococcus pneumoniae 25 82 107 <0.001
Influenza virus type A 41 9 50
Legionella pneumophila 5 8 13
Haemophilus influenzae 1 3 4
Staphylococcus aureus 0 3 3
Pseudomonas aeruginosa 0 3 3
Other pathogens 0 6 6
Treatments, %
Quinolones 52.9 51.8 52.7
Penicillins 34.4 37.3 35.6
Macrolides 5.9 1.7 4.1
Cephalosporins 1.5 2.5 1.9
Sulfonamide 0.3 0.8 0.5
Combined therapy, %
Amoxicillin/Azithromycin 4.1 0.0 2.4 <0.001
Cephalosporin/Azithromycin 0.9 5.8 2.8
Change of treatment, % 5.9 8.7 7.1 NS

aOutpatient: includes patients diagnosed in primary care centres and emergency rooms at hospitals.

Sicras-Mainar et al.

Sicras-Mainar et al. BMC Infectious Diseases 2012 12:283   doi:10.1186/1471-2334-12-283

Open Data